Tandem Diabetes Care (Nasdaq:TNDM) shares ticked up after hours today on third-quarter results that topped the consensus forecast. Shares of TNDM rose 5% to $35.85 apiece in post-market trading today. The San Diego-based automated insulin delivery system maker reported losses of $23.3 million. That equals 35¢ per share on sales of nearly $244 million for […]
MassDevice Earnings Roundup
Dexcom submits 15-day CGM to FDA, beats Street in Q3
Dexcom (Nasdaq:DXCM) announced that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA. G7, the company’s latest-generation continuous glucose monitor (CGM), presently has approval for a 10-day wear time. Shares of DXCM were up slightly at the opening of trading today. Yesterday evening, Dexcom also reported third-quarter results […]
Medtronic wants to be No. 1 in automated insulin delivery as Q1 results highlight Diabetes growth
Medtronic (NYSE:MDT) reported more growth in its Diabetes unit as the company’s recent moves signal its intent in the competitive insulin pump market. The company’s first-quarter (fiscal 2025) results included $647 million in revenue from the Diabetes unit. That marked 11% year-over-year growth from the same three-month period a year ago. U.S. revenues grew in […]
Embecta stock gets a boost on Q3 beats, patch pump program remains on track
Embecta (Nasdaq:EMBC) shares rose significantly today on third-quarter results that came in well ahead of the consensus forecast. Shares of EMBC ticked up 14% to $16.39 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose slightly. It’s the second recent boost for Embecta’s […]
Senseonics misses Q2 sales expectations but 365-day CGM is on track for Q4 launch
Senseonics (NYSE:SENS) shares dipped after hours today on second-quarter results that missed the consensus sales forecast. Shares of SENS fell 4% to 39¢ apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up nearly 1%. The Germantown, Maryland-based long-term implantable […]
Insulet reports Omnipod sales growth of 26% in Q2, raises guidance despite EPS miss
Insulet (Nasdaq:PODD) stock is down on second-quarter results that came in mixed compared to the consensus forecast. Shares of PODD were down more than 7% to $184.56 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up slightly. Yesterday evening, the Acton, […]
Tandem stock soars after hours on Q2 beats, increased guidance as pump shipments rise again
Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after the market closed today on second-quarter results that beat the consensus forecast. Shares of TNDM rose more than 22% to $43.20 apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down […]
Insulet preliminary Q2 revenue report beats The Street
Insulet (Nasdaq: PODD) saw its revenue increase 23% year-over-year to $488 million in the second quarter, which ended June 30. That’s according to preliminary Q2 revenue numbers that Insulet released today. The result beats the consensus of Wall Street analysts, who expected that Insulet had $460.27 million in revenue in Q2. The maker of Omnipod […]
Dexcom stock falls on Q2 results that came up shy of ‘high standards’
Dexcom (Nasdaq:DXCM) (Nasdaq:DXCM) shares plummeted today on second-quarter results that came in mixed compared to the consensus forecast. Shares of DXCM fell more than 40% to $63.96 apiece in morning trading today. MassDevice‘s MedTech 100 Index was down slightly. The San Diego-based continuous glucose monitor (CGM) maker yesterday evening reported profits of $143.5 million. That […]
Senseonics posts Q1 sales beat, submits 365-day iCGM to FDA
Senseonics (NYSE:SENS) shares ticked up after the market closed today on first-quarter results that came in ahead of the consensus sales forecast. Shares of SENS rose 8.1% to 41¢ apiece in post-market trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down slightly. […]
